tradingkey.logo
tradingkey.logo
검색

Evotec SE

EVO
관심 목록에 추가
2.900USD
+0.050+1.75%
종가 07/02, 13:00ET시세는 15분 지연됩니다
1.03B시가총액
손실P/E TTM

자세한 내용은 Evotec SE 회사

Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.

Evotec SE 정보

종목 코드 EVO
회사 이름Evotec SE
상장일Oct 11, 1999
CEOWojczewski (Christian)
직원 수4827
유형Depository Receipt
회계 연도 종료Oct 11
주소Essener Bogen 7
도시HAMBURG
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가Germany
우편 번호22419
전화4940560810
웹사이트https://www.evotec.com/
종목 코드 EVO
상장일Oct 11, 1999
CEOWojczewski (Christian)

Evotec SE의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Dr. Cord Dohrmann, Ph.D.
Dr. Cord Dohrmann, Ph.D.
Chief Scientific Officer, Member of the Management Board
Chief Scientific Officer, Member of the Management Board
--
--
Prof. Dr. Iris Loewfriedrich
Prof. Dr. Iris Loewfriedrich
Independent Chairwoman of the Supervisory Board
Independent Chairwoman of the Supervisory Board
--
--
Mr. Roland Sackers
Mr. Roland Sackers
Independent Vice Chairman of the Supervisory Board
Independent Vice Chairman of the Supervisory Board
--
--
Dr. Constanze Ulmer-Eilfort
Dr. Constanze Ulmer-Eilfort
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Volker Braun
Mr. Volker Braun
Senior Vice President, Head of Global Investor Relations and ESG
Senior Vice President, Head of Global Investor Relations and ESG
--
--
Ms. Camilla Macapili Languille
Ms. Camilla Macapili Languille
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Ms. Laetitia Rouxel
Ms. Laetitia Rouxel
Chief Financial Officer, Member of the Management Board
Chief Financial Officer, Member of the Management Board
--
--
Mrs. Aurelie Dalbiez
Mrs. Aurelie Dalbiez
Chief People Officer, Member of the Management Board
Chief People Officer, Member of the Management Board
--
--
Dr. Christian Wojczewski
Dr. Christian Wojczewski
Chief Executive Officer, Member of the Management Board
Chief Executive Officer, Member of the Management Board
--
--
Dr. Duncan Mchale
Dr. Duncan Mchale
Member of the Supervisory Board
Member of the Supervisory Board
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. Cord Dohrmann, Ph.D.
Dr. Cord Dohrmann, Ph.D.
Chief Scientific Officer, Member of the Management Board
Chief Scientific Officer, Member of the Management Board
--
--
Prof. Dr. Iris Loewfriedrich
Prof. Dr. Iris Loewfriedrich
Independent Chairwoman of the Supervisory Board
Independent Chairwoman of the Supervisory Board
--
--
Mr. Roland Sackers
Mr. Roland Sackers
Independent Vice Chairman of the Supervisory Board
Independent Vice Chairman of the Supervisory Board
--
--
Dr. Constanze Ulmer-Eilfort
Dr. Constanze Ulmer-Eilfort
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Volker Braun
Mr. Volker Braun
Senior Vice President, Head of Global Investor Relations and ESG
Senior Vice President, Head of Global Investor Relations and ESG
--
--
Ms. Camilla Macapili Languille
Ms. Camilla Macapili Languille
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--

자주 묻는 질문

Evotec SE의 상위 5대 주주는 누구인가요?

Evotec SE의 상위 5대 주주는 다음과 같습니다: Dr. Cord Dohrmann, Ph.D.

Evotec SE(EVO)의 주식을 보유한 기관은 몇 개입니까?

2026Q1 기준으로, Evotec SE의 주식을 보유한 기관은 총 81곳이며, 이들이 보유한 주식의 총 가치는 약 9.58M로 전체 발행 주식의 2.69%를 차지합니다. 이는 2025Q4 대비 -584606.00 증가한 수치입니다.